Tradr Readies Leveraged Single-Stock ETFs on ALAB and DDOG

Rhea-AI Summary

Tradr ETFs has announced the upcoming launch of two first-to-market leveraged single-stock ETFs on Astera Labs (NASDAQ: ALAB) and Datadog (NASDAQ: DDOG), scheduled for August 12, 2025. The new ETFs - Tradr 2X Long DDOG Daily ETF (Cboe: DOGD) and Tradr 2X Long ALAB Daily ETF (Cboe: LABX) - will expand Tradr's leveraged ETF lineup to 21 funds.

Since late-April, Tradr has introduced 2X long leveraged ETFs on 12 stocks, accumulating approximately $400 million in assets under management. These ETFs are specifically designed for sophisticated investors and professional traders seeking high-conviction investment opportunities in the AI theme.

Positive

• First-to-market position in leveraged ETFs for ALAB and DDOG
• Strong AUM growth with $400 million across 12 recent launches
• Expansion of product lineup to 21 funds
• Strategic focus on high-growth AI sector stocks

Negative

• High risk due to 2X leverage potentially magnifying losses
• Limited to sophisticated investors and professional traders only
• Risk of total loss if underlying security moves adversely by more than 50% in one day

Insights

Financial Products Specialist

Tradr launching 2X leveraged ETFs on ALAB and DDOG expands AI-focused investment options but carries significant volatility risks for investors.

Tradr ETFs is expanding its leveraged ETF lineup with two new products tracking Astera Labs (ALAB) and Datadog (DDOG), both positioned as growth stocks within the artificial intelligence sector. These products, trading under symbols LABX and DOGD, will offer 2X daily leveraged exposure to the underlying securities.

The announcement represents Tradr's continued push into the leveraged single-stock ETF space, having launched similar products on 12 other growth-oriented companies since April. Their collective assets under management have reached approximately $400 million, indicating meaningful market adoption for these specialized trading vehicles.

Tradr specifically highlights Datadog's recent inclusion in the S&P 500 and Astera Labs' "meteoric revenue growth" as key attractions for potential investors. The company is clearly targeting active traders seeking amplified exposure to high-growth technology companies within the AI ecosystem.

However, the press release contains extensive risk disclosures that warrant serious attention. These leveraged products can produce dramatic losses - if the underlying security moves 50% against the fund's position in a single day, investors could lose their entire investment. The company explicitly states these products are for "sophisticated investors and professional traders" and are intended as short-term trading vehicles rather than long-term investments.

These products represent new trading instruments for market participants interested in ALAB and DDOG, potentially increasing trading activity around these securities. The leveraged nature of these ETFs means they will need to regularly rebalance holdings, which could marginally impact price action in the underlying stocks during market volatility.

First-to-market 2X ETFs on Astera Labs and Datadog set to trade on Tuesday

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced today that it expects to launch two first-to-market leveraged single-stock ETFs on Astera Labs Inc. (Nasdaq: ALAB) and Datadog Inc. (Nasdaq: DDOG) on Tuesday, August 12. This launch will grow Tradr's leveraged ETF lineup to 21 funds.

The two new funds are:

• Tradr 2X Long DDOG Daily ETF (Cboe: DOGD)
• Tradr 2X Long ALAB Daily ETF (Cboe: LABX)

"Both stocks represent very compelling growth narratives within the AI theme, and we are excited to soon make these two ETFs available to the Tradr Tribe", said Matt Markiewicz, Tradr's Head of Product and Capital Markets. "Datadog's recent addition to the S&P 500 Index is a remarkable achievement as it's only been public for just under six years, while Astera, which IPO'd in March 2024, has seen meteoric revenue growth over the last several years."

Since late-April, Tradr ETFs has introduced a suite of 2X long leveraged ETFs on 12 captivating stocks, including CoreWeave (CWVX), Tempus AI (TEMT), AppLovin (APPX), D-Wave Quantum (QBTX), and NuScale Power (SMU). As of August 7, 2025, the collective assets under management of the 12 launches stands at approximately $400 million.

For detailed information on Tradr ETFs and the significant risks involved with inverse and leveraged ETFs, please visit www.tradretfs.com.

About Tradr ETFs
Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.

IMPORTANT RISK INFORMATION

Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.

Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.

Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.

The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.

ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.

ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.

Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000722

View original content to download multimedia:https://www.prnewswire.com/news-releases/tradr-readies-leveraged-single-stock-etfs-on-alab-and-ddog-302525223.html

SOURCE Tradr ETFs

FAQ

What are the new leveraged ETFs that Tradr is launching for ALAB and DDOG?

Tradr is launching the Tradr 2X Long DDOG Daily ETF (Cboe: DOGD) and Tradr 2X Long ALAB Daily ETF (Cboe: LABX), both offering 2X leverage on their respective stocks.

When will Tradr's new leveraged ETFs for ALAB and DDOG begin trading?

The new leveraged ETFs are scheduled to begin trading on Tuesday, August 12, 2025.

How much assets under management (AUM) does Tradr have in its recent leveraged ETF launches?

Tradr has accumulated approximately $400 million in assets under management across its 12 recent leveraged ETF launches as of August 7, 2025.

What are the main risks of Tradr's leveraged ETFs for ALAB and DDOG?

The main risks include potential magnification of losses due to 2X leverage, possibility of total loss if underlying security moves adversely by more than 50% in one day, and these ETFs are only suitable for sophisticated investors and professional traders.

How many leveraged ETFs will Tradr have after launching ALAB and DDOG ETFs?

After launching these two new ETFs, Tradr's leveraged ETF lineup will expand to 21 funds.